Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex

Virology

Volumn 255, Issue 2, 1999, Pages 337-346

  Liu, Yi ^a   Suñé, Carlos ^a   Garcia Blanco, Mariano A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; VIRUS ENZYME;

ARTICLE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; TRANSCRIPTION INITIATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0345718508     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9585     Document Type: Article

References (56)

1. Arya S. K., Guo C. S., Josephs F., Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science. 229:1985;69-73.
2. Berger J., Hauber J., Hauber R., Geiger R., Cullen B. R. Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 66:1988;1-10.
3. Berkhout B., Jeang K.-T. Trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J. Virol. 63:1989;5501-5504.
4. Berkhout B., Jeang K.-T. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:1992;139-149.
5. Berkhout B. R., Silverman H., Jeang K.-T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell. 59:1989;273-282.
6. Blair W. S., Fridell R. A., Cullen B. R. Synergistic enhancement of both initiation and elongation by acidic transcription activation domains. EMBO J. 15:1996;1658-1665.
7. Blau J., Xiao H., McCracken S., O'Hare P., Greenblatt L., Bentley D. Three functional classes of transcriptional activation domain. Mol. Cell. Biol. 16:1996;2044-2055.
8. Bohjanen P. R., Liu Y., Garcia-Blanco M. A. TAR RNA decoys inhibit Tat-activated HIV-1 transcription after preinitiation complex formation. Nucleic Acids Res. 25:1997;4481-4486.
9. Carroll R., Peterlin B. M., Derse D. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J. Virol. 66:1992;2000-2007.
10. Cujec T. P., Cho H., Maldonado E., Meyer J., Reinberg D., Peterlin B. M. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17:1997a;1817-1823.
11. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin B. M. The HIV transactivator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997b;2645-2657.
12. Cullen B. R. The HIV-1 Tat protein: An RNA sequence-specific processivity factor. Cell. 63:1990;655-657.
13. Cullen B. R. Does HIV-1 Tat induce a change in viral initiation rights. Cell. 73:1993;417-420.
14. Deuschele U., Hipskind R. A., Bujard H. RNA polymerase II transcription blocked byEscherichia coli. Science. 248:1990;480-483.
15. Dvir A., Conaway R. C., Conaway J. W. A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes. Proc. Natl. Acad. Sci. USA. 94:1997;9006-9010.
16. Dvir A., Garrett K. P., Chalut C., Egly J.-M., Conaway J. W., Conaway R. C. A role for ATP and TFIIH in activation of the RNA polymerase II preinitiation complex prior to transcription initiation. J. Biol. Chem. 271:1996;7245-7248.
17. Feinberg M. B., Baltimore D., Frankel A. D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA. 88:1991;4045-4049.
18. Feng S., Holland E. C. HIV-1 Tat trans-activation requires the loop sequence within TAR. Nature. 334:1988;165-167.
19. Fujinaga K., Cujec T. P., Peng J., Garriga J., Price D. H., Grana X., Peterlin B. M. The ability of positive transcription elongation factor b to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:1998;7154-7159.
20. Garcia-Martinez L., Mavankal G., Neveu J., Lane W., Ivanov D., Gaynor R. Purification of a Tat-associated kinase reveals a TFIIH complex that modulated HIV-1 transcription. EMBO J. 16:1997;2836-2850.
21. Garcia-Martinez L. F., Ivanov D., Gaynor R. B. Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complex. J. Biol. Chem. 272:1997;6951-6958.
22. Gaynor R. B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 193:1995;51-77.
23. Goodrich J., Tjian R. Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell. 77:1994;145-156.
24. Greenblatt J., Nodwell J. R., Mason S. W. Transcriptional antitermination. Nature. 364:1993;401-406.
25. Herrmann C. H., Rice A. P. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology. 197:1993;601-608.
26. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620.
27. Kao S.-Y., Calman A. F., Luciw P. A., Peterlin B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by Tat gene product. Nature. 330:1987;489-493.
28. Kashanchi F., Piras G., Radonovich M. F., Duvall J. F., Fattaey A., Chiang C.-M., Roeder R. G., Brady J. N. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature. 367:1994;295-299.
29. Kato H., Sumimoto H., Pognonec P., Chen C.-H., Rosen C. A., Roeder R. G. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:1992;655-666.
30. Keen N. J., Churcher M. J., Karn J. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 17:1997;5260-5272.
31. Keen N. J., Gait M. J., Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA. 93:1996;2505-2510.
32. Lu X., Welsh T. M., Peterlin B. M. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Virol. 67:1993;1752-1760.
33. Madore S. J., Cullen B. R. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67:1993;3703-3711.
34. Mancebo H. S. Y., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1997;2633-2644.
35. Marciniak R. A., Calnan B. J., Frankel A. D., Sharp P. A. HIV-1 Tat protein trans-activates transcription in vitro. Cell. 63:1990;791-802.
36. Marciniak R. A., Sharp P. A. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:1991;4189-4196.
37. Marshall N., Peng J., Xie Z., Price D. H. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:1996;27176-27183.
38. Marshall N., Price D. H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:1995;12335-12338.
39. Olsen H. S., Rosen C. A. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:1992;5594-5597.
40. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
41. Reines D., Mote J. J. Elongation factor SII-dependent transcription by RNA polymerase II through a sequence-specific DNA-binding protein. Proc. Natl. Acad. Sci. USA. 90:1993;1917-1921.
42. Rice A. P., Carlotti F. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. J. Virol. 64:1990;1864-1868.
43. Riggs A. D., Newby R. F., Bourgeois S. lac repressor-operator interaction. II. Effect of galactosides and other ligands. J. Miol. Biol. 51:1970;303-314.
44. Rosen C. A., Sodroski J. G., Haseltine W. A. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell. 41:1985;813-823.
45. Selby M. J., Bain E. S., Luciw P. A., Peterlin B. M. Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev. 3:1989;547-558.
46. Sodroski J., Patarca R., Rosen C., Wong-Staal F., Haseltine W. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science. 229:1985;74-77.
47. Suñé C., Garcia-Blanco M. A. Transcriptionaltrans. J. Virol. 69:1995;3098-3107.
48. Suñé C., Hayashi T., Liu Y., Lane W. S., Young R. A., Garcia-Blanco M. A. CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 17:1997;6029-6039.
49. Veschambre P., Roisin A., Jalinot P. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcriptional factor TFIIB. J. General Virol. 78:1997;2235-2245.
50. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A. A novel cdk9-associated c-type cyclin interacts directly with HIV-1 Tat and mediated its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
51. Yang X., Gold M. O., Tang D. N., Lewis D. E., Aguilar-Cordova E., Rice A. P., Herrmann C. H. Tak, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA. 94:1997;12331-12336.
52. Yang X., Herrmann C. H., Rice A. P. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:1996;4576-4584.
53. Yankulov K., Blau J., Purton T., Roberts S., Bentley D. L. Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell. 77:1994;749-759.
54. Zhou Q., Sharp P. A. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:1995;321-328.
55. Zhou Q., Sharp P. A. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science. 274:1996;605-610.
56. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.